Evidence map›Paper›PMID 30055608›Full record

Observational studyRespiratory research2018

Impact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPD.

Nicholas P Williams, Kristoffer Ostridge, Jeanne-Marie Devaster, Viktoriya Kim, Ngaire A Coombs, Simon Bourne, Stuart C Clarke, Stephen Harden, Ausami Abbas, Emmanuel Aris and 7 more

Registry-linked trialOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in Respiratory research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01360398 (Contribution of Infectious Pathogens to Acute Respiratory Illness in Adults and Elderly), which is not on this map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01360398 nacompletednot on this map

Contribution of Infectious Pathogens to Acute Respiratory Illness in Adults and Elderly

TypeinterventionalSponsorGlaxoSmithKlineRan2011 to 2014Enrolled127ConditionsRespiratory DisordersArmsBlood sample, Sputum sample, Nasopharyngeal swab, Urine sample, End tidal breath sample
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Thoracic Imaging at Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review.International journal of chronic obstructive pulmonary disease · 2020
    Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Risk Factors and Clinical Characteristics of Acute Kidney Injury in Patients with COVID-19: A Systematic Review and Meta-Analysis.Pathophysiology : the official journal of the International Society for Pathophysiology · 2023
    Review
  10. Article
  11. Clinical features predicting COVID-19 mortality risk.European journal of translational myology · 2022
    Article
  12. COPD Exacerbation Syndrome: The Spanish Perspective on an Old Dilemma.International journal of chronic obstructive pulmonary disease · 2022
    Review
  13. Review
  14. TRPV4 Inhibition Exerts Protective Effects Against Resistive Breathing Induced Lung Injury.International journal of chronic obstructive pulmonary disease
    Article
  15. Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD.International journal of chronic obstructive pulmonary disease
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 2 countries.

Nicholas P WilliamsClinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK. NPWilliams@doctors.org.uk.ORCID 0000-0002-2866-682X
Kristoffer OstridgeClinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
Jeanne-Marie DevasterGSK Vaccines, Rixensart, Belgium.
Viktoriya KimClinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
Ngaire A CoombsPrimary Care and Population Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Simon BourneClinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
Stuart C ClarkeClinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
Stephen HardenDepartment of Radiology, University Hospital Southampton NHS Foundation Trust, Southampton General Hospital, Tremona Road, Southampton, UK.
Ausami AbbasDepartment of Radiology, University Hospital Southampton NHS Foundation Trust, Southampton General Hospital, Tremona Road, Southampton, UK.
Emmanuel ArisGSK Vaccines, Rixensart, Belgium.
Christophe LambertGSK Vaccines, Rixensart, Belgium.
Andrew TuckFaculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Anthony WilliamsWessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
Stephen WoottonSouthampton NIHR Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Karl J StaplesClinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
Tom M A WilkinsonClinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
AERIS Study Group
Southampton General Hospital · GBGlaxoSmithKline (Belgium) · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOPD patients have increased risk of developing pneumonia, which is associated with poor outcomes. It can be symptomatically indistinguishable from exacerbations, making diagnosis challenging. Studies of pneumonia in COPD have focused on hospitalised patients and are not representative of the ambulant COPD population. Therefore, we sought to determine the incidence and aetiology of acute exacerbation events with evidence of pneumonic radiographic infiltrates in an outpatient COPD cohort.

methodsOne hundred twenty-seven patients with moderate to very severe COPD aged 42-85 years underwent blood and sputum sampling over one year, at monthly stable visits and within 72 h of exacerbation symptom onset. 343 exacerbations with chest radiographs were included.

results20.1% of exacerbations had pneumonic infiltrates. Presence of infiltrate was highly seasonal (Winter vs summer OR 3.056, p = 0.027). In paired analyses these exacerbation events had greater increases in systemic inflammation. Bacterial detection rate was higher in the pneumonic group, with Haemophilus influenzae the most common bacteria in both radiological groups. Viral detection and sputum microbiota did not differ with chest radiograph appearance.

conclusionsIn an outpatient COPD cohort, pneumonic infiltrates at exacerbation were common, and associated with more intense inflammation. Bacterial pathogen detection and lung microbiota were not distinct, suggesting that exacerbations and pneumonia in COPD share common infectious triggers and represent a continuum of severity rather than distinct aetiological events.

trial registrationTrial registration Number: NCT01360398 .

Indexed as

Disease ProgressionAdultAgedAged, 80 and overCohort StudiesFemaleHumansMaleMiddle AgedPneumoniaProspective StudiesPulmonary Disease, Chronic ObstructiveCOPDExacerbationsInfiltratesPneumonia

Identifiers

PMID30055608
PMCPMC6064093
OpenAlexW2884607621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.